NasdaqGS:ANABBiotechs
Should AnaptysBio’s (ANAB) Russell Index Removal Prompt a Rethink of Its Liquidity and Investor Base?
In June 2026, AnaptysBio, Inc. was removed from several Russell indices, including the Russell Microcap, Russell 3000E, and related growth benchmark indices, triggering index rebalancing by passive funds.
This broad removal from key Russell benchmarks may influence how investors perceive AnaptysBio’s visibility, liquidity, and role within the small-cap biotech universe.
We’ll now examine how AnaptysBio’s exit from multiple Russell indices shapes its investment narrative, especially around...